Scientific Sessions Agenda

 Thursday, June 11, 2026

4:00 PM - 6:00 PM Session I | 2026 Opening Session
6:00 PM - 7:00 PM Opening Night Exhibit Hall Kickoff Reception

 Friday, June 12, 2026 | Decoding Discovery: From Global Mechanism to Patient Medicine

9:00 AM - 10:30 AM

Session II | From Genetic Discovery to Clinical Action

  • CRISPR-Based Gene Editing: Rewriting the Code for Lifetime Lipid Control and Cardiovascular Prevention 
  • Genotype-Informed Prevention: The Economic Case for Cascade Screening in Familial Hypercholesterolemia
  • Unlocking the Future of Cardiology: The Next Generation of Therapies Driven by Genetic Discovery 
10:30 AM - 11:00 AM  Abstract Author Q&A in Exhibit Hall
11:00 AM - 11:20 AM NLA Incoming President's Address
11:20 AM - 12:00 PM  W. Virgil Brown Distinguished Achievement Award Lectureship
12:00 PM - 12:20 PM  NLA Scientific Updates 
12:20 PM - 1:20 PM  Lunch in Exhibit Hall | Expert Theaters
1:20 PM - 1:50 PM Session III | Late Breakers
1:50 PM- 2:20 PM  Abstract Author Q&A in Exhibit Hall 
2:20 PM - 3:50 PM

Session IV | Severe Hypertriglyceridemia: A Comprehensive Exploration of Uncommon Causes and Emerging Insights

  • The Genetic Underpinnings of Severe Hypertriglyceridemia
  • GPIHBP1 Autoantibody Syndrome Explained
  • The Relationship Between Severe Hypertriglyceridemia and Advanced Subclinical Atherosclerosis 
3:50 PM- 4:20 PM  Abstract Author Q&A in Exhibit Hall
4:20 PM - 6:05 PM Session V | NLA/EAS Joint Session
Primary Prevention of ASCVD: a Joint Session from the European Atherosclerosis Society and the National Lipid Association

 Saturday, June 13, 2026 | Legacy, Data, and the Next Generation of Care

9:00 AM - 10:30 AM

Session VI | Rewriting the Rules for Primary Prevention: New Outcomes from Intensive LDL-C Reduction in High-Risk Patients

  • The Original PCSK9 Inhibitor Trials: FOURIER, ODYSSEY Outcomes, FOURIER OLE
  • What We've Learned about LDL-C and Outcomes
  • VESALIUS-CV 
10:30 AM - 11:00 AM  Abstract Author Q&A in Exhibit Hall
11:00 AM - 12:30 PM Session VII | Abstract Award Winners
12:30 PM- 1:30 PM  Lunch in Exhibit Hall | Expert Theaters
1:30 PM - 2:35 PM Session VIII | Young Investigator Award Winners
2:35 PM - 2:50 PM  Break 
2:50 PM - 4:00 PM Session IX | Lipid Scholarship Program Case Discussions
4:00 PM - 4:15 PM Break
4:15 PM - 5:45 PM

Session X | Managing the Child's Trajectory: Intervening on Early Cardiometabolic Risk

  • A Generation at Risk: Understanding and Mitigating Insulin Resistance in Youth
  • Pre-Atherosclerotic Imaging in Pediatrics: Capturing Early Cardiovascular Risk
  • Nurturing the Next Generation: A Family Affair of Health
5:45 PM - 6:05 PM NLA: A Historical Perspective
6:30 PM - 7:45 PM  NLA Honors and Awards Ceremony

 Sunday, June 14, 2026 | Systems in Flux: Redefining Risk and Resilience

9:00 AM - 10:30 AM

Session XI | Deciphering Women's Risk: New Perspectives on Lipids, Pre-eclampsia, and Navigating HRT in Cardiometabolic Health

  • When Pregnancy Predicts Heart Health: The Critical Role of Lipids in Pre-eclampsia
  • From Caution to Clarity: Re-evaluating the Risk-Benefit Profile of HRT after the FDA Policy Shift
10:30 AM - 10:45 AM Break
10:45 AM - 12:15 PM

Session XII | Inflammation: The GI, Metabolic and Renal Link

  • Lipoprotein(a): The Genetic Inflammatory Fuel Driving Total Cardiovascular Risk
  • The Role of Non-Invasive Imaging in Assessing MASLD-Related Inflammation and Fibrosis
  • Modulating the Gut Microbiome: A Novel Strategy for Attenuating Inflammation and Reducing Cardiorenal Risk
12:15 PM Adjourn